特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の創薬アウトソーシング市場:医薬品の種類、サービス、用途、エンドユーザー別、地域別 - 規模、シェア、動向、および予測

Outsourced Drug Discovery Market by Drug Type, by Services, by Application, by End Users, by Region - Size, Share, Trends, and Forecast 2019 - 2026

発行 Coherent Market Insights 商品コード 906226
出版日 ページ情報 英文 157 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=107.98円で換算しております。
世界の創薬アウトソーシング市場:医薬品の種類、サービス、用途、エンドユーザー別、地域別 - 規模、シェア、動向、および予測 Outsourced Drug Discovery Market by Drug Type, by Services, by Application, by End Users, by Region - Size, Share, Trends, and Forecast 2019 - 2026
出版日: 2019年07月18日 ページ情報: 英文 157 Pages
概要

当レポートは世界の創薬アウトソーシング市場について調査しており、市場の機会や動向、成長および阻害要因、医薬品の種類・サービス・用途・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 調査の目的および仮定

  • 調査目的
  • 仮定
  • 略語

第2章 市場の概要

  • レポートの説明
    • 市場の定義および範囲
  • エグゼクティブサマリー
    • 医薬品の種類別
    • サービス別
    • 用途別
    • エンドユーザー別
    • 地域別
  • COM (Coherent Opportunity Map)

第3章 市場力学、規制、動向分析

  • 市場力学
    • 成長要因
    • 阻害要因
    • 市場機会
  • 影響分析
  • 市場動向
  • 主な開発
  • 技術の進歩
  • 歴史的概要
  • 合併および買収
  • 規制シナリオ
  • ポーターのファイブフォース分析
  • PEST分析

第4章 世界市場:医薬品の種類別

  • イントロダクション
  • 低分子医薬品
  • 高分子医薬品

第5章 世界市場:サービス別

  • イントロダクション
  • 前臨床開発
  • ターゲット検証および機能情報学
  • ターゲットの識別およびスクリーニング
  • リードの識別および対象の最適化
  • その他

第6章 世界市場:用途別

  • イントロダクション
  • 腫瘍学
  • 眼科
  • 血液学
  • 免疫調節
  • 抗感染薬
  • 皮膚科
  • 神経学
  • 呼吸器
  • 循環器
  • その他

第7章 世界市場:エンドユーザー別

  • イントロダクション
  • 製薬およびバイオテクノロジー企業
  • 受託研究機関(CRO)
  • 受託製造組織(CMO)

第8章 世界市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • アフリカ
  • 中東

第9章 競合情勢

  • ヒートマップ分析
  • 企業プロファイル
    • Aurigene Accelerating Discovery
    • Bioduro LLC.
    • Charles River Laboratories (CRL)
    • TCG Lifesciences
    • Evotec AG
    • Syngene International Ltd.
    • Jubilant Biosys Ltd.
    • Pharmaron Inc.
    • Shanghai Medicilon Inc.
    • Sundia Meditech Co. Ltd.
  • アナリストの見解

第10章 セクション

  • 参照資料
  • 調査方法
  • Coherent Market Insightについて
目次

Title:
Outsourced Drug Discovery Market by Drug Type (Small Molecule Drugs and Large Molecule Drugs), by Services (Preclinical Developments, Target validation and Functional Informatics, Target Identification and Screening, Lead Identification and Candidate Optimization, and Others), by Application (Oncology, Ophthalmology, Hematology, Immunomodulation, Anti-Infective Drugs, Dermatology, Neurology, Cardiology, and Others), by End Users (Pharmaceutical and Biotechnological Companies, Contract research Organization, and Contract Manufacturing Organization), by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Trends, and Forecast 2019 - 2026.

Outsourced drug discovery is a contract-based process, which is conducted by the contract research organizations (CRO) and contract manufacturing organization (CMO). Contract research organization provides support to pharmaceutical, biotechnology, and medical device industries for drug discovery and development. CRO facilitates the various services such as biopharmaceutical development, biologic assay development, preclinical research, clinical trials, and pharmacovigilance, for drug discovery and development.

Market Dynamics:

New strategies adopted by key players related to outsourcing drug discovery is expected to drive growth of global outsourced drug discovery market. For instance, in June 2019, GlaxoSmithKline (GSK), a British drug manufacturing company collaborated with the University of California to establish a state-of-the-art laboratory for CRISPR technologies, the Laboratory for Genomics Research (LGR), in San Francisco. The new laboratory will investigate how gene mutations cause diseases, and also develop new technologies using CRISPR to rapidly accelerate the discovery of new medicines.

Furthermore, extension of partnership activities is expected to propel global outsourced drug discovery market growth. For instance, in March 2017, Charles River Laboratories (CRL) extended its partnership with Chiesi Farmaceutici. Under this partnership, Charles River Laboratories (CRL) extended its longstanding, strategic, integrated drug discovery program (Respiratory Program). The respiratory program is related to the preclinical drug development for treatment of respiratory diseases and rare diseases.

Key features of the study:

  • This report provides in-depth analysis of the outsourced drug discovery market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period (2019-2026), considering 2017, as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global outsourced drug discovery market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include, Aurigene Accelerating Discovery, Bioduro LLC, Charles River Laboratories (CRL), Chempartner, TCG Lifesciences, Evotec AG, Syngene International Ltd. Jubilant Biosys Ltd, Pharmaron Inc., Shanghai Medicilon, and Sundia Meditech Co. Ltd.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global outsourced drug discovery market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for anesthesia device market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Outsourced Drug Discovery Market, By Drug Type:
    • Small Molecule Drugs
    • Large Molecule Drugs
  • Global Outsourced Drug Discovery market, By Services:
    • Preclinical Development
    • Target Validation and Functional Informatics
    • Target Identification and Screening
    • Lead Identification and Candidate Optimization
    • Others
  • Global Outsourced Drug Discovery Market, By Application
    • Oncology
    • Ophthalmology
    • Hematology
    • Immunomodulation
    • Anti-Infective Drugs
    • Dermatology
    • Pulmonology
    • Cardiology
    • Others
  • Global Outsourced Drug Discovery market, By End User
    • Pharmaceutical and Biotechnological Companies
    • Contract Research Organization
    • Contract Manufacturing Organization
  • Global Outsourced Drug Discovery market, By Region:
    • North America
      • By Country:
    • U.S.
    • Canada
      • By Drug Type:
    • Small Molecule Drugs
    • Large Molecule Drugs
      • By Services:
    • Preclinical Development
    • Target Validation and Functional Informatics
    • Target Identification and Screening
    • Lead Identification and Candidate Optimization
    • Others
      • By Application
    • Oncology
    • Ophthalmology
    • Hematology
    • Immunomodulation
    • Anti-Infective Drugs
    • Dermatology
    • Pulmonology
    • Cardiology
    • Others
      • By End User
    • Pharmaceutical and Biotechnological Companies
    • Contract Research Organization
    • Contract Manufacturing Organization
    • Europe
      • By Country:
    • U.K.
    • Germany
    • Italy
    • Spain
    • France
    • Russia
    • Rest of Europe
      • By Drug Type:
    • Small Molecule Drugs
    • Large Molecule Drugs
      • By Services:
    • Preclinical Development
    • Target Validation and Functional Informatics
    • Target Identification and Screening
    • Lead Identification and Candidate Optimization
    • Others
      • By Application
    • Oncology
    • Ophthalmology
    • Hematology
    • Immunomodulation
    • Anti-Infective Drugs
    • Dermatology
    • Pulmonology
    • Cardiology
    • Others
      • By End User
    • Pharmaceutical and Biotechnological Companies
    • Contract Research Organization
    • Contract Manufacturing Organization
    • Asia Pacific
      • By Country:
    • Australia
    • India
    • China
    • Japan
    • ASEAN
    • South Korea
    • Rest of Asia Pacific
      • By Drug Type:
    • Small Molecule Drugs
    • Large Molecule Drugs
      • By Services:
    • Preclinical Development
    • Target Validation and Functional Informatics
    • Target Identification and Screening
    • Lead Identification and Candidate Optimization
    • Others
      • By Application
    • Oncology
    • Ophthalmology
    • Hematology
    • Immunomodulation
    • Anti-Infective Drugs
    • Dermatology
    • Pulmonology
    • Cardiology
    • Others
      • By End User
    • Pharmaceutical and Biotechnological Companies
    • Contract Research Organization
    • Contract Manufacturing Organization
    • Latin America
      • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
      • By Drug Type:
    • Small Molecule Drugs
    • Large Molecule Drugs
      • By Services:
    • Preclinical Development
    • Target Validation and Functional Informatics
    • Target Identification and Screening
    • Lead Identification and Candidate Optimization
    • Others
      • By Application
    • Oncology
    • Ophthalmology
    • Hematology
    • Immunomodulation
    • Anti-Infective Drugs
    • Dermatology
    • Pulmonology
    • Cardiology
    • Others
      • By End User
    • Pharmaceutical and Biotechnological Companies
    • Contract Research Organization
    • Contract Manufacturing Organization
    • Middle East
      • By Country/Region:
    • GCC
    • Israel
    • Rest of Middle East
      • By Drug Type:
    • Small Molecule Drugs
    • Large Molecule Drugs
      • By Services:
    • Preclinical Development
    • Target Validation and Functional Informatics
    • Target Identification and Screening
    • Lead Identification and Candidate Optimization
    • Others
      • By Application
    • Oncology
    • Ophthalmology
    • Hematology
    • Immunomodulation
    • Anti-Infective Drugs
    • Dermatology
    • Pulmonology
    • Cardiology
    • Others
      • By End User
    • Pharmaceutical and Biotechnological Companies
    • Contract Research Organization
    • Contract Manufacturing Organization
    • Africa
      • By Country/Region:
    • South Africa
    • Central Africa
    • North Africa
      • By Drug Type:
    • Small Molecule Drugs
    • Large Molecule Drugs
      • By Services:
    • Preclinical Development
    • Target Validation and Functional Informatics
    • Target Identification and Screening
    • Lead Identification and Candidate Optimization
    • Others
      • By Application
    • Oncology
    • Ophthalmology
    • Hematology
    • Immunomodulation
    • Anti-Infective Drugs
    • Dermatology
    • Pulmonology
    • Cardiology
    • Others
      • By End User
    • Pharmaceutical and Biotechnological Companies
    • Contract Research Organization
    • Contract Manufacturing Organization
  • Company Profiles
    • Aurigene Accelerating Discovery,*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Bioduro LLC.
    • Charles River Laboratories (CRL)
    • TCG Lifesciences
    • Evotec AG
    • Syngene International Ltd.
    • Jubilant Biosys Ltd.
    • Pharmaron Inc.
    • Shanghai Medicilon Inc.
    • Sundia Meditech Co. Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Drug Type
    • Market Snippet, By Services
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Technology Advancements
  • Historical Overview
  • Merger and Acquisition
  • Regulatory Scenario
  • PORTER'S Five Forces
  • PEST Analysis

4. Global Outsourced Drug Discovery Market, By Drug Type, 2018 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Small Molecule Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Large Molecule Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

5. Global Outsourced Drug Discovery Market, By Services, 2018 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Preclinical Development
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Target Validation and Functional Informatics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Target Identification and Screening
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Lead Identification and Candidate Optimization
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

6. Global Outsourced Drug Discovery Market, By Application, 2018 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Ophthalmology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Hematology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Immunomodulation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Anti-Infective Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Dermatology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Neurology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Pulmonology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Cardiology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

7. Global Outsourced Drug Discovery Market, By End Users, 2018 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Pharmaceutical and Biotechnological Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Contract Research Organization (CRO)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Contract Manufacturing Organization (CMO)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

8. Global Outsourced Drug Discovery Market, By Region, 2018 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, By Region, 2017 - 2026
    • Regional Trends
  • North America
    • Market Size and Forecast, By Drug Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Services, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Drug Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Services, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Drug Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Services, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Drug Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Services, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Drug Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Services, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country/Region, 2016 - 2026, (US$ Million)
    • North Africa
    • Central Africa
    • South Africa
  • Middle East
    • Market Size and Forecast, By Drug Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Services, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country/Region, 2016 - 2026, (US$ Million)
    • GCC Countries
    • Israel
    • Rest of Middle East

9. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Aurigene Accelerating Discovery
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Bioduro LLC.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Charles River Laboratories (CRL)
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • TCG Lifesciences
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Evotec AG
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Syngene International Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Jubilant Biosys Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Pharmaron Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Shanghai Medicilon Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Sundia Meditech Co. Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
  • Analyst Views

10. Section

  • References
  • Research Methodology
  • About us and Sales Contact